NKE Factor-Based Stock Analysis

Validea's guru fundamental report highlights NIKE Inc. (NKE) as the top performer among 22 strategies, achieving an 88% rating using the Partha Mohanram P/B Growth Investor model. This model targets low book-to-market stocks exhibiting characteristics for sustained future growth, indicating significant interest in NKE's underlying fundamentals and valuation for growth-oriented investors. While NKE passed most of the model's criteria, including return on assets and cash flow, it notably failed the research and development to assets test.

Analysis

NIKE Inc. (NKE) has been identified as a high-potential, large-cap growth stock, scoring a strong 88% on Validea's Partha Mohanram P/B Growth Investor model. This quantitative screen is notable for its focus on identifying low book-to-market stocks with fundamentals that suggest sustained future growth. According to the model's specific criteria, NKE exhibits robust financial health, passing tests for its book-to-market ratio, return on assets (ROA), cash flow from operations to assets, and stability in both ROA and sales variance. The company also demonstrates effective capital allocation in key areas, meeting the criteria for advertising and capital expenditures relative to its asset base. The single point of failure in this comprehensive screen was the 'Research and Development to Assets' ratio, indicating that, according to this model's metrics, R&D spending is not a primary driver of its favorable growth profile.

Key Decisions for Investors

• Investors with a growth-oriented mandate should view the 88% quantitative score and the pass on multiple fundamental metrics, such as ROA and cash flow stability, as a strong positive signal for NKE.
• The identified weakness in the 'Research and Development to Assets' ratio requires further diligence; specifically, investors should assess if the company's growth is sufficiently supported by its brand strength and marketing, as suggested by the pass on the advertising metric, rather than traditional R&D.
• Given the stock's alignment with a model designed to find growth 'winners', existing holders may find this analysis validates their position, while prospective investors could consider this a compelling entry point, contingent on their own risk assessment of the low R&D investment.